Annual Total Assets
$29.26 M
+$1.75 M+6.38%
December 31, 2023
Summary
- As of February 21, 2025, ONCY annual total assets is $29.26 million, with the most recent change of +$1.75 million (+6.38%) on December 31, 2023.
- During the last 3 years, ONCY annual total assets has risen by +$2.33 million (+8.65%).
- ONCY annual total assets is now -34.13% below its all-time high of $44.43 million, reached on December 31, 2010.
Performance
ONCY Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$17.96 M
-$5.46 M-23.30%
September 30, 2024
Summary
- As of February 21, 2025, ONCY quarterly total assets is $17.96 million, with the most recent change of -$5.46 million (-23.30%) on September 30, 2024.
- Over the past year, ONCY quarterly total assets has stayed the same.
- ONCY quarterly total assets is now -68.24% below its all-time high of $56.53 million, reached on March 31, 2011.
Performance
ONCY Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ONCY Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +6.4% | 0.0% |
| 3 y3 years | +8.7% | -34.7% |
| 5 y5 years | +168.1% | -34.7% |
ONCY Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.7% | +6.4% | -50.1% | at low |
| 5 y | 5-year | -18.7% | +94.5% | -60.5% | +19.3% |
| alltime | all time | -34.1% | +494.0% | -68.2% | +131.3% |
Oncolytics Biotech Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.96 M(-23.3%) |
| Jun 2024 | - | $23.41 M(-9.0%) |
| Mar 2024 | - | $25.72 M(-12.1%) |
| Dec 2023 | $29.26 M(+6.4%) | $29.26 M(-13.7%) |
| Sep 2023 | - | $33.91 M(+40.6%) |
| Jun 2023 | - | $24.12 M(-7.6%) |
| Mar 2023 | - | $26.12 M(-5.1%) |
| Dec 2022 | $27.51 M(-23.6%) | $27.51 M(-3.4%) |
| Sep 2022 | - | $28.49 M(-8.8%) |
| Jun 2022 | - | $31.23 M(-12.3%) |
| Mar 2022 | - | $35.60 M(-1.1%) |
| Dec 2021 | $35.98 M(+33.6%) | $35.98 M(-12.7%) |
| Sep 2021 | - | $41.23 M(-9.2%) |
| Jun 2021 | - | $45.41 M(+5.8%) |
| Mar 2021 | - | $42.92 M(+59.4%) |
| Dec 2020 | $26.93 M(+79.0%) | $26.93 M(+15.4%) |
| Sep 2020 | - | $23.34 M(-7.9%) |
| Jun 2020 | - | $25.34 M(+4.0%) |
| Mar 2020 | - | $24.36 M(+61.9%) |
| Dec 2019 | $15.05 M(+37.9%) | $15.05 M(+22.3%) |
| Sep 2019 | - | $12.30 M(+5.5%) |
| Jun 2019 | - | $11.66 M(-5.5%) |
| Mar 2019 | - | $12.33 M(+13.0%) |
| Dec 2018 | $10.91 M(-24.4%) | $10.91 M(-22.3%) |
| Sep 2018 | - | $14.05 M(-10.0%) |
| Jun 2018 | - | $15.61 M(+42.7%) |
| Mar 2018 | - | $10.94 M(-24.2%) |
| Dec 2017 | $14.43 M(+31.9%) | $14.43 M(+20.9%) |
| Sep 2017 | - | $11.94 M(-11.7%) |
| Jun 2017 | - | $13.52 M(+69.7%) |
| Mar 2017 | - | $7.97 M(-27.2%) |
| Dec 2016 | $10.95 M(-44.5%) | $10.95 M(-21.9%) |
| Sep 2016 | - | $14.02 M(-15.1%) |
| Jun 2016 | - | $16.52 M(-6.9%) |
| Mar 2016 | - | $17.74 M(-10.1%) |
| Dec 2015 | $19.73 M(+33.2%) | $19.73 M(-14.5%) |
| Sep 2015 | - | $23.09 M(-13.6%) |
| Jun 2015 | - | $26.74 M(+7.8%) |
| Mar 2015 | - | $24.80 M(+67.5%) |
| Dec 2014 | $14.81 M(-44.1%) | $14.81 M(-8.6%) |
| Sep 2014 | - | $16.20 M(-13.8%) |
| Jun 2014 | - | $18.79 M(-9.8%) |
| Mar 2014 | - | $20.84 M(-21.4%) |
| Dec 2013 | $26.51 M(+19.4%) | $26.51 M(-16.0%) |
| Sep 2013 | - | $31.55 M(-15.8%) |
| Jun 2013 | - | $37.47 M(-14.0%) |
| Mar 2013 | - | $43.57 M(+96.3%) |
| Dec 2012 | $22.19 M | $22.19 M(-25.1%) |
| Sep 2012 | - | $29.65 M(-17.1%) |
| Jun 2012 | - | $35.78 M(-24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $47.52 M(+34.7%) |
| Dec 2011 | $35.29 M(-20.6%) | $35.29 M(-14.9%) |
| Sep 2011 | - | $41.49 M(-19.1%) |
| Jun 2011 | - | $51.31 M(-9.2%) |
| Mar 2011 | - | $56.53 M(+27.3%) |
| Dec 2010 | $44.43 M(+31.5%) | $44.43 M(+117.0%) |
| Sep 2010 | - | $20.47 M(-18.1%) |
| Jun 2010 | - | $24.99 M(-15.8%) |
| Mar 2010 | - | $29.68 M(-12.1%) |
| Dec 2009 | $33.78 M(+197.6%) | $33.78 M(+252.6%) |
| Sep 2009 | - | $9.58 M(-12.7%) |
| Jun 2009 | - | $10.97 M(+41.3%) |
| Mar 2009 | - | $7.76 M(-31.6%) |
| Dec 2008 | $11.35 M(-56.9%) | $11.35 M(-10.8%) |
| Sep 2008 | - | $12.73 M(-31.7%) |
| Jun 2008 | - | $18.64 M(-30.2%) |
| Mar 2008 | - | $26.72 M(+1.4%) |
| Dec 2007 | $26.35 M(-8.5%) | $26.35 M(-22.8%) |
| Sep 2007 | - | $34.12 M(-3.6%) |
| Jun 2007 | - | $35.40 M(-2.2%) |
| Mar 2007 | - | $36.20 M(+25.8%) |
| Dec 2006 | $28.78 M(-27.7%) | $28.78 M(-15.3%) |
| Sep 2006 | - | $34.00 M(-7.0%) |
| Jun 2006 | - | $36.57 M(-2.2%) |
| Mar 2006 | - | $37.37 M(-6.2%) |
| Dec 2005 | $39.83 M(+21.2%) | $39.83 M(+15.6%) |
| Sep 2005 | - | $34.47 M(+10.9%) |
| Jun 2005 | - | $31.07 M(-7.2%) |
| Mar 2005 | - | $33.48 M(+1.9%) |
| Dec 2004 | $32.86 M(+63.8%) | $32.86 M(+40.6%) |
| Sep 2004 | - | $23.36 M(-0.2%) |
| Jun 2004 | - | $23.41 M(+20.6%) |
| Mar 2004 | - | $19.41 M(-3.2%) |
| Dec 2003 | $20.06 M(+76.2%) | $20.06 M(+25.8%) |
| Sep 2003 | - | $15.95 M(+15.0%) |
| Jun 2003 | - | $13.87 M(+22.2%) |
| Mar 2003 | - | $11.35 M(-0.3%) |
| Dec 2002 | $11.39 M(-4.6%) | $11.39 M(+3.7%) |
| Sep 2002 | - | $10.98 M(-15.2%) |
| Jun 2002 | - | $12.94 M(+27.0%) |
| Mar 2002 | - | $10.19 M(-14.7%) |
| Dec 2001 | $11.94 M(-17.3%) | $11.94 M(-5.7%) |
| Sep 2001 | - | $12.67 M(-6.8%) |
| Jun 2001 | - | $13.59 M(+2.2%) |
| Mar 2001 | - | $13.30 M(-7.8%) |
| Dec 2000 | $14.43 M(+192.9%) | $14.43 M(-4.6%) |
| Sep 2000 | - | $15.12 M(+5.7%) |
| Jun 2000 | - | $14.31 M(-2.9%) |
| Mar 2000 | - | $14.73 M |
| Dec 1999 | $4.93 M | - |
FAQ
- What is Oncolytics Biotech annual total assets?
- What is the all time high annual total assets for Oncolytics Biotech?
- What is Oncolytics Biotech annual total assets year-on-year change?
- What is Oncolytics Biotech quarterly total assets?
- What is the all time high quarterly total assets for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly total assets year-on-year change?
What is Oncolytics Biotech annual total assets?
The current annual total assets of ONCY is $29.26 M
What is the all time high annual total assets for Oncolytics Biotech?
Oncolytics Biotech all-time high annual total assets is $44.43 M
What is Oncolytics Biotech annual total assets year-on-year change?
Over the past year, ONCY annual total assets has changed by +$1.75 M (+6.38%)
What is Oncolytics Biotech quarterly total assets?
The current quarterly total assets of ONCY is $17.96 M
What is the all time high quarterly total assets for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly total assets is $56.53 M
What is Oncolytics Biotech quarterly total assets year-on-year change?
Over the past year, ONCY quarterly total assets has changed by $0.00 (0.00%)